Prediction of Cancer Incidence and Mortality in Korea, 2020
- PMID: 32178488
- PMCID: PMC7176954
- DOI: 10.4143/crt.2020.203
Prediction of Cancer Incidence and Mortality in Korea, 2020
Abstract
Purpose: This study aimed to report the projected cancer incidence and mortality for the year 2020 to estimate Korea's current cancer burden.
Materials and methods: Cancer incidence data from 1999 to 2017 were obtained from the Korea National Cancer Incidence Database, and cancer mortality data from 1993 to 2018 were acquired from Statistics Korea. Cancer incidence and mortality were projected by fitting a linear regression model to observed age-specific cancer rates against observed years and then by multiplying the projected age-specific rates by the age-specific population. A Joinpoint regression model was used to determine the year in which the linear trend changed significantly; we only used the data of the latest trend.
Results: In total, 243,263 new cancer cases and 80,546 cancer deaths are expected to occur in Korea in 2020. The most common cancer site is expected to be the lung, followed by the stomach, thyroid, colon/rectum, and breast. These five cancers types are expected to represent half of the overall burden of cancer in Korea. The most common type of cancer among people who die is expected to be lung cancer, followed by liver, colon/rectal, pancreatic, and stomach cancers.
Conclusion: The incidence rates for all types of cancer in Korea are estimated to decrease gradually. These up-to-date estimates of the cancer burden in Korea could be an important resource for planning and evaluating cancer-control programs.
Keywords: 2020; Forecasting; Incidence; Korea; Mortality; Neoplasms.
Conflict of interest statement
Conflict of interest relevant to this article was not reported.
Figures



Similar articles
-
Prediction of Cancer Incidence and Mortality in Korea, 2019.Cancer Res Treat. 2019 Apr;51(2):431-437. doi: 10.4143/crt.2019.139. Epub 2019 Mar 18. Cancer Res Treat. 2019. PMID: 30913864 Free PMC article.
-
Prediction of Cancer Incidence and Mortality in Korea, 2021.Cancer Res Treat. 2021 Apr;53(2):316-322. doi: 10.4143/crt.2021.290. Epub 2021 Mar 17. Cancer Res Treat. 2021. PMID: 33735558 Free PMC article.
-
Prediction of Cancer Incidence and Mortality in Korea, 2022.Cancer Res Treat. 2022 Apr;54(2):345-351. doi: 10.4143/crt.2022.179. Epub 2022 Mar 21. Cancer Res Treat. 2022. PMID: 35313101 Free PMC article.
-
Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan-Korea Oncology Consortium.Int J Environ Res Public Health. 2022 Sep 17;19(18):11727. doi: 10.3390/ijerph191811727. Int J Environ Res Public Health. 2022. PMID: 36142000 Free PMC article. Review.
-
Global cancer statistics in the year 2000.Lancet Oncol. 2001 Sep;2(9):533-43. doi: 10.1016/S1470-2045(01)00486-7. Lancet Oncol. 2001. PMID: 11905707 Review.
Cited by
-
Minimally invasive surgery for patients with advanced stage endometrial cancer.Int J Med Sci. 2021 Jan 1;18(5):1153-1158. doi: 10.7150/ijms.52293. eCollection 2021. Int J Med Sci. 2021. PMID: 33526975 Free PMC article.
-
Enhanced Efficacy of Combined Therapy with Checkpoint Kinase 1 Inhibitor and Rucaparib via Regulation of Rad51 Expression in BRCA Wild-Type Epithelial Ovarian Cancer Cells.Cancer Res Treat. 2021 Jul;53(3):819-828. doi: 10.4143/crt.2020.1013. Epub 2020 Dec 16. Cancer Res Treat. 2021. PMID: 33332934 Free PMC article.
-
The burden and long-term trends of breast cancer by different menopausal status in China.J Natl Cancer Cent. 2024 Jul 2;4(4):326-334. doi: 10.1016/j.jncc.2024.04.007. eCollection 2024 Dec. J Natl Cancer Cent. 2024. PMID: 39735447 Free PMC article.
-
Neoadjuvant versus adjuvant chemotherapy in bladder cancer: a nationwide cohort study.J Cancer Res Clin Oncol. 2022 Nov;148(11):3135-3144. doi: 10.1007/s00432-022-03926-1. Epub 2022 Jan 21. J Cancer Res Clin Oncol. 2022. PMID: 35061097 Free PMC article.
-
Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review.Cancers (Basel). 2021 Apr 1;13(7):1647. doi: 10.3390/cancers13071647. Cancers (Basel). 2021. PMID: 33916008 Free PMC article. Review.
References
-
- Statistics Korea [Internet] Daejeon: Statistics Korea; 2020. [cited 2020 Feb 8]. Available from: http://kosis.kr.
-
- Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st revision. Geneva: World Health Organization; 2013.
-
- World Health Organization . International statistical classification of diseases and related health problems. 10th rev. Geneva: World Health Organization; 1994.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical